International Journal of Drug Policy
Volume 17, Issue 2 , Pages 61-69 , March 2006

Harm reduction by a “user-run” organization: A case study of the Vancouver Area Network of Drug Users (VANDU)

  • Thomas Kerr

      Affiliations

    • The Canadian HIV/AIDS Legal Network, 417 Rue Saint Pierre, Suite 408 Montreal, Que., Canada H2Y 2M4
    • British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, University of British Columbia, Canada
    • Corresponding Author InformationCorresponding author at: The Canadian HIV/AIDS Legal Network, 417 Rue Saint Pierre, Suite 408 Montreal, Que., Canada H2Y 2M4. Tel.: +1 514 397 6828x222; fax: +1 514 397 8570.
  • ,
  • Will Small

      Affiliations

    • British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, University of British Columbia, Canada
  • ,
  • Wallace Peeace

      Affiliations

    • Vancouver Area Network of Drug Users (VANDU), Canada
  • ,
  • David Douglas

      Affiliations

    • Vancouver Area Network of Drug Users (VANDU), Canada
  • ,
  • Adam Pierre

      Affiliations

    • Vancouver Area Network of Drug Users (VANDU), Canada
  • ,
  • Evan Wood

      Affiliations

    • British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, University of British Columbia, Canada
    • Department of Health Care and Epidemiology, University of British Columbia, Canada

References 

  1. Broadhead RS, Heckathorn DD, Grund JP, Stern LS, Anthony DL. Drug users versus outreach workers in combating AIDS: Preliminary results of a peer-driven intervention. Journal of Drug Issues. 1995;25(3):531–564
  2. Broadhead RS, Heckathorn DD, Weakliem DL, Anthony DL, Madray H, Mills RJ, et al. Harnessing peer networks as an instrument for AIDS prevention: Results from a peer-driven intervention. Public Health Reports. 1998;113(Suppl. 1):42–57
  3. Bula F. Drug user group wins right to be heard in court. Vancouver Sun; 2002;March 1, B3.
  4. Castells M. The power of identity. Oxford: Blackwell Publishers, Inc; 1996;
  5. Cottier LB, Compton WM, Ben Abdallah A, Cunningham-Williams R, Abram F, Fichtenbaum C, et al. Peer-delivered interventions reduce HIV risk behaviours among out-of-treatment drug abusers. Public Health Reports. 1998;113(Suppl. 1):31–41
  6. Crofts N, Herkt D. A history of peer-based drug-user groups in Australia. Journal of Drug Issues. 1993;25:599–616
  7. Darke S, Kaye S, Ross J. Geographical injecting locations among injecting drug users in Sydney, Australia. Addiction. 2001;96(2):241–246
  8. Engler M. Towards the rights of the poor: Human rights in Liberation Theology. Journal of Religious Ethics. 2000;28(3):339–365
  9. Epstein S. Impure science: AIDS, activism and the politics of knowledge. Berkeley and Los Angeles: University of California Press; 1996;
  10. Eurchuk R. Agency accused of misrepresenting study. Georgia Straight. 2002, June 27;11
  11. Grund JP, Blanken P, Adriaans NF, Kaplan CD, Barendregt C, Meeuwsen M. Reaching the unreached: Targeting hidden IDU populations with clean needles via known user groups. Journal of Psychoactive Drugs. 1992;24(1):41–47
  12. Kerr T, Wood E, Palepu A, Small D, Tyndall MW. The potential use of safer injection facilities among injection drug users in Vancouver's Downtown Eastside. Canadian Medical Association Journal. 2003;169(8):1–5
  13. Klee H, Morris J. Factors that characterize street injectors. Addiction. 1995;90(6):837–842
  14. Latkin CA. Outreach in natural settings: The use of peer leaders for HIV prevention among injecting drug users’ networks. Public Health Reports. 1998;113(Suppl. 1):151–159
  15. Latkin C, Mandell W, Vlahov D, Oziemkowska M, Knowlton A, Celentano D. My place, your place, and no place: Behaviour settings as a risk factor for HIV-related injection practices of drug users in Baltimore, Maryland. American Journal of Community Psychology. 1994;22(3):415–430
  16. O'Shaughnessy MV, Montaner JS, Strathdee S, Schechter MT. Deadly public policy. International Conference on AIDS. 1998;12:982;(abstract no. 44233)
  17. Palepu A, Tyndall MW, Leon H, Muller J, O'Shaughnessy MV, Schechter MT, et al. Hospital utilization and costs in a cohort of injection drug users. Canadian Medical Association Journal. 2001;165:415–420
  18. Patrick DM, Strathdee SA, Archibald , Ofner M, Craib KJ, Cornelisse PG, et al. Determinants of HIV seroconversion in injection drug users during a period of rising prevalence in Vancouver. International Journal of STD & AIDS. 1997;8(7):437–445
  19. Power R, Jones S, Kearus J, Ward J, Perera J. Drug user networks, coping strategies, and HIV prevention in the community. Journal of Drug Issues. 1995;25(3):565–581
  20. Rich JD, Strong L, Towe CW, McKenzie M. Obstacles to needle exchange participation in Rhode Island. Journal of Acquired Immune Deficiency Syndromes. 1999;21(5):396–400
  21. Stake RE. Case study methods in educational research: Seeking sweet water. In:  Jaeger RM editors. Complementary methods for research in education. Washington, DC: American Educational Research Association; 1988;p. 253–278
  22. Stoller N. Less from the damned: Queers, whores and junkies respond to AIDS. New York: Routledge; 1998;
  23. Statistics Canada . Population Census of Canada. Ottawa: Government of Canada; 1996;
  24. Strathdee SA, Patrick DM, Currie SL, Cornelisse PG, Rekart ML, Montaner JS, et al. Needle exchange is not enough: Lessons from the Vancouver injecting drug use study. AIDS. 1997;11(8):F59–F65
  25. Tyndall MW, Currie S, Spittal P, Li K, Wood E, O'Shaughnessy MV, et al. Intensive injection cocaine use as a primary risk factor for in the Vancouver HIV-1 epidemic. AIDS. 2003;17:887–893
  26. Vancouver Sun. (2002). Wednesday June 5, 2002: Police Thwart Service to Help Addicts (p. Bl).
  27. Wood E, Kerr T, Small W, Spittal P, Hogg R, Tyndall M, et al. Evaluation of an ‘unsanctioned’ peer-run syringe exchange programme. Journal of Urban Health. 2003;80(3):455–464
  28. Wood E, Spittal PM, Kerr T, Small W, O'Shaughnessy , Schechter M. requiring help injecting as a risk factor for HIV infection in the Vancouver epidemic: Implications for HIV prevention. Canadian Journal of Public Health. 2003;94(5):355–359
  29. Wood E, Tyndall MW, Spittal PM, Li K, Hogg RS, Montaner JS, et al. Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange program. AIDS. 2002;16(6):941–943
  30. Wood E, Tyndall MW, Spittal P, Hogg R, O'Shaughnessy MV, Schechter MT. Needle exchange and difficulty with needle access during an ongoing HIV epidemic. International Journal of Drug Policy. 2002;13(2):95–102

PII: S0955-3959(06)00006-5

doi: 10.1016/j.drugpo.2006.01.003

International Journal of Drug Policy
Volume 17, Issue 2 , Pages 61-69 , March 2006